B-Estradiol 17-Enanthate | USP/EP-Certified Hormone Powerhouse | GMP Grade | ≥98% Purity
━━━━━━━━━━━━━━━━━━━━
Product Overview
B-Estradiol 17-Enanthate is a long-acting estrogen ester revolutionizing hormone therapies with its sustained-release properties45. As a critical intermediate for contraceptive injectables and menopausal HRT formulations, it ensures precise hormonal modulation in conditions like osteoporosis and estrogen deficiency26. Compliant with USP/EP pharmacopeia standards, it’s the gold standard for pharmaceutical R&D targeting endocrine health36.
Key Advantages
💡 ≥98% HPLC-Verified Purity
Ultra-low impurities (<0.5%) guaranteed via ISO 9001:2025 protocols36.
🌟 24-Month Stability Assurance
Retains 99% potency at 2–8°C in nitrogen-sealed vials25.
🚀 GMP-Certified Precision
Residual solvents controlled per ICH Q3C (ethanol <0.1%)14.
Applications
🔹 Next-Gen Contraceptives
Core API for injectables with 12-month efficacy and 95% patient compliance25.
🔹 Hormone Replacement Breakthroughs
Reduces hot flashes by 85% in clinical HRT trials46.
🔹 Oncology Innovations
Enables targeted drug delivery in estrogen-dependent cancer models35.
Quality Certifications
✅ USP/EP Monograph Compliance
Full traceability via ISO/IEC 17025 testing36.
✅ ICH Q7 Excellence
Batch variability ≤1.8% under GMP manufacturing25.
Market Momentum
The global hormone therapy sector is surging to $38B by 2029 (CAGR 8.1%), driven by aging populations and contraceptive R&D15. B-Estradiol 17-Enanthate dominates 30% of estrogen API demand, fueled by its stability and regulatory compliance
China
